Answers are grounded in this paper and cite their sources.
A broad variety of medicinal chemistry approaches can be used for the identification of hits, generation of leads, as well as to accelerate the development of high quality drug candidates. Structure-based drug design (SBDD) methods are becoming increasingly powerful, versatile and more widely used. This review summarizes current developments in structure-based virtual screening and receptor-based pharmacophores, highlighting achievements as well as challenges, along with the value of structure-based lead optimization, with emphasis on recent examples of successful applications for the identification of novel active compounds.
No takes yet. Share an insight, caveat, or question.
Andricopulo et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: